Assessing the Efficacy of a High-Dose Lidocaine-Tetracaine Cream for the Treatment of Peripheral Neuropathic Pain

NCT07396129 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Neuropathic Chronic Pain

Interventions

DRUG: Lidocaine (23%) + Tetracaine (7%)
DRUG: Placebo cream application

Sponsor

Pontificia Universidad Catolica de Chile